4//SEC Filing
BIOTIME INC 4
Accession 0001209191-15-066702
$LCTXCIK 0000876343operating
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 6:52 PM ET
Size
11.7 KB
Accession
0001209191-15-066702
Insider Transaction Report
Form 4
BIOTIME INCBTX
Cartt Stephen LaHue
Director
Transactions
- Purchase
Common Shares, no par value
2015-08-18$2.90/sh+17,200$49,832→ 155,125 total - Purchase
Common Shares, no par value
2015-08-14$2.65/sh+18,400$48,756→ 98,525 total - Purchase
Common Shares, no par value
2015-08-17$2.83/sh+39,400$111,478→ 137,925 total
Holdings
- 20,000
Option to Purchase Common Shares
Exercise: $3.43Exp: 2019-11-03→ Common Shares (20,000 underlying) - 20,000
Option to Purchase Common Shares
Exercise: $3.57Exp: 2020-06-30→ Common Shares (20,000 underlying)
Footnotes (5)
- [F1]The price of $2.6498 per share represents a weighted average of prices ranging from $2.63 to $2.679 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F2]The price of $2.8294 per share represents a weighted average of prices ranging from $2.69 to $2.99 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F3]The price of $2.8972 per share represents a weighted average of prices ranging from $2.86 to $3.00 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F4]Will become exercisable in four equal quarterly installments after the date of grant on July 1, 2015 based upon continued service on the board of directors.
- [F5]5,000 options became exercisable on December 31, 2014; March 31, 2015; and June 30, 2015. The remaining 5,000 options will become exercisable on September 30, 2015 based upon continued service on the board of directors.
Documents
Issuer
BIOTIME INC
CIK 0000876343
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0000876343
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 6:52 PM ET
- Size
- 11.7 KB